BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31580514)

  • 1. Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease.
    Sansoè G; Aragno M; Wong F
    Liver Int; 2020 Jan; 40(1):18-31. PubMed ID: 31580514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.
    Li XC; Zhuo JL
    Curr Hypertens Rep; 2016 Aug; 18(8):63. PubMed ID: 27372447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
    Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
    Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.
    Sansoè G; Aragno M
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():3362391. PubMed ID: 37476705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrarenal renin-angiotensin system in hypertension.
    Carey RM
    Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the renin-angiotensin system actually hypertensive?
    Bérard E; Niel O; Rubio A
    Pediatr Nephrol; 2014 Jun; 29(6):951-60. PubMed ID: 23740033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin angiotensin system in liver diseases: Friend or foe?
    Simões E Silva AC; Miranda AS; Rocha NP; Teixeira AL
    World J Gastroenterol; 2017 May; 23(19):3396-3406. PubMed ID: 28596676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
    Rajapaksha IG; Gunarathne LS; Angus PW; Herath CB
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
    Zimpelmann J; Kumar D; Levine DZ; Wehbi G; Imig JD; Navar LG; Burns KD
    Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megalin-Mediated Endocytosis in the Kidney Proximal Tubule: Relevance to Regulation of the Renal Renin-Angiotensin System.
    Hummelgaard S; Weyer K
    Nephron; 2023; 147(3-4):244-249. PubMed ID: 36096093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
    Kobori H; Nangaku M; Navar LG; Nishiyama A
    Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving concepts on regulation and function of renin in distal nephron.
    Prieto MC; Gonzalez AA; Navar LG
    Pflugers Arch; 2013 Jan; 465(1):121-32. PubMed ID: 22990760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.
    Kovarik JJ; Kopecky C; Antlanger M; Domenig O; Kaltenecker CC; Werzowa J; Hecking M; Mahr S; Grömmer M; Wallner C; Aumayr K; Kain R; Zuckermann A; Poglitsch M; Säemann MD
    J Heart Lung Transplant; 2017 Mar; 36(3):355-365. PubMed ID: 27773450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat.
    Sechi LA; Griffin CA; Giacchetti G; Valentin JP; Llorens-Cortes C; Corvol P; Schambelan M
    Hypertension; 1996 Sep; 28(3):403-8. PubMed ID: 8794824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal nerve stimulation leads to the activation of the Na+/H+ exchanger isoform 3 via angiotensin II type I receptor.
    Pontes RB; Crajoinas RO; Nishi EE; Oliveira-Sales EB; Girardi AC; Campos RR; Bergamaschi CT
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F848-56. PubMed ID: 25656367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of stimulated intrarenal angiotensinogen in hypertension.
    Satou R; Shao W; Navar LG
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):181-90. PubMed ID: 25987608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
    Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
    Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.